Skip to main content
Premium Trial:

Request an Annual Quote

Veritas Genetics MyBRCA HiRisk

Veritas Genetics has launched myBRCA HiRisk, a new 26-gene comprehensive HBOC screening test specifically designed for high-risk populations. This high-risk panel identifies germline mutation in 26 genes, including BRCA1 and BRCA2, which are associated with increased risk for developing breast and ovarian cancer as well as other associated cancers. The panel also test for structural rearrangements in BRCA1 and BRCA2 and includes genes known to be associated with Lynch syndrome, Cowden syndrome, Li-fraumeni syndrome, peutz-Jeghers and several other genetic syndromes. The panel is priced at $299 USD.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.